Alector GAAP EPS of -$0.34, revenue of $6.2M
Source: SeekingAlpha
2026-02-26 02:05:30 ET
More on Alector
- Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst
- Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript
- Alector appoints Neil Berkley as chief financial officer
- Seeking Alpha’s Quant Rating on Alector
- Historical earnings data for Alector
Read the full article on Seeking Alpha
For further details see:
Alector GAAP EPS of -$0.34, revenue of $6.2M
Alector Inc.
NASDAQ: ALEC
ALEC Trading
8.65% G/L:
$2.135 Last:
305,336 Volume:
$1.94 Open:
ALEC Latest News
February 25, 2026 04:05:00 pm
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 24, 2026 08:00:00 am
Alector to Participate in the TD Cowen 46th Annual Health Care Conference
December 12, 2025 04:05:00 pm
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer
ALEC Stock Data
$209,025,069
87,976,086
3.13%
48
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
